Literature DB >> 21710115

Gut overgrowth harms the critically ill.

Andy Petros, Nia Taylor, Hendrick K van Saene, Luciano Silvestri.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21710115     DOI： 10.1007/s00134-011-2287-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Probiotics to prevent ventilator-associated pneumonia: no robust evidence from randomized controlled trials.

Authors:  Luciano Silvestri; Luciano van Silvestri; Hendrick K van Saene; Dario Gregori; Susanna Agostini; Marisella Francescon; Nia Taylor
Journal:  Crit Care Med       Date:  2010-07       Impact factor: 7.598

2.  Microbial gut overgrowth guarantees increased spontaneous mutation leading to polyclonality and antibiotic resistance in the critically ill.

Authors:  H K F van Saene; N Taylor; V Damjanovic; R E Sarginson
Journal:  Curr Drug Targets       Date:  2008-05       Impact factor: 3.465

Review 3.  How to classify infections in intensive care units--the carrier state, a criterion whose time has come?

Authors:  H K van Saene; V Damjanovic; A E Murray; M A de la Cal
Journal:  J Hosp Infect       Date:  1996-05       Impact factor: 3.926

4.  Selective digestive tract decontamination: A tough pill to swallow.

Authors:  Kevin B Laupland; David N Fisman
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

5.  Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality.

Authors:  Guy J Oudhuis; Dennis C Bergmans; Tom Dormans; Jan-Harm Zwaveling; Alfons Kessels; Martin H Prins; Ellen E Stobberingh; Annelies Verbon
Journal:  Intensive Care Med       Date:  2010-08-19       Impact factor: 17.440
  5 in total
  1 in total

Review 1.  Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth.

Authors:  Luciano Silvestri; Miguel A de la Cal; Hendrick K F van Saene
Journal:  Intensive Care Med       Date:  2012-09-22       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.